Corbus Prescribed drugs (NASDAQ:CRBP) reported its This autumn earnings outcomes on Tuesday, March 8, 2022 at 08:05 AM.
Here is what traders have to know in regards to the announcement.
Earnings
Corbus Prescribed drugs beat estimated earnings by 27.27%, reporting an EPS of $-0.08 versus an estimate of $-0.11.
Income was down $658.20 thousand from the identical interval final yr.
Previous Earnings Efficiency
Final quarter the corporate beat on EPS by $0.09 which was adopted by a 0.95% enhance within the share value the subsequent day.
Here is a have a look at Corbus Prescribed drugs’s previous efficiency:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | This autumn 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.12 | -0.15 | -0.25 |
| EPS Precise | -0.02 | -0.15 | -0.14 | -0.10 |
| Income Estimate | 650.00K | 870.00K | 960.00K | 1.49M |
| Income Precise | 97.32K | 136.56K | 647.82K | 658.20K |
To trace all upcoming earnings bulletins, click on to make use of Benzinga Earnings Calendar.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
